Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · IEX Real-Time Price · USD
22.74
-5.72 (-20.10%)
At close: Jul 2, 2024, 4:00 PM
22.70
-0.04 (-0.18%)
After-hours: Jul 2, 2024, 7:45 PM EDT
Pacira BioSciences Employees
Pacira BioSciences had 712 employees as of December 31, 2023. The number of employees decreased by 3 or -0.42% compared to the previous year.
Employees
712
Change (1Y)
-3
Growth (1Y)
-0.42%
Revenue / Employee
$957,520
Profits / Employee
$98,975
Market Cap
1.06B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 712 | -3 | -0.42% |
Dec 31, 2022 | 715 | 18 | 2.58% |
Dec 31, 2021 | 697 | 73 | 11.70% |
Dec 31, 2020 | 624 | 18 | 2.97% |
Dec 31, 2019 | 606 | 88 | 16.99% |
Dec 31, 2018 | 518 | 29 | 5.93% |
Dec 31, 2017 | 489 | -14 | -2.78% |
Dec 31, 2016 | 503 | 16 | 3.29% |
Dec 31, 2015 | 487 | 40 | 8.95% |
Dec 31, 2014 | 447 | 137 | 44.19% |
Dec 31, 2013 | 310 | 154 | 98.72% |
Dec 31, 2012 | 156 | 23 | 17.29% |
Dec 31, 2011 | 133 | 50 | 60.24% |
Dec 31, 2010 | 83 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Owens & Minor | 22,200 |
Gyre Therapeutics | 593 |
Ironwood Pharmaceuticals | 267 |
Tango Therapeutics | 140 |
Pharvaris | 82 |
PCRX News
- 4 weeks ago - Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029 - GlobeNewsWire
- 7 weeks ago - Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes - GlobeNewsWire
- 2 months ago - Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase program - GlobeNewsWire
- 2 months ago - Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024 - GlobeNewsWire
- 3 months ago - Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 3 months ago - Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee - GlobeNewsWire